Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05435014 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT05435014 · ClinicalTrials.gov record · last posted 2026-08-18

T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma

Name: T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma — clinical trial record (NCT05435014)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusTerminated

PhasePhase 1/2

SponsorT-ACE Medical Co., Ltd

Started2022-09-13

View on ClinicalTrials.gov ↗

Why the trial stopped

T-ACE Medical Co., Ltd. hereby submits this formal notification to the U.S. Food and Drug Administration (FDA) to request the permanent discontinuation and withdrawal of Investigational New Drug application IND 152626.

from the ClinicalTrials.gov record

The phase I/II, double-blind, randomized study will investigate the efficacy and safety of TACE/TAE treatment with T-ACE Oil in patients with unresectable hepatocellular carcinoma.

Protocol amendment history 1 change detected by DataLookout

2026-08-19

Suspended trial terminated

Trial Details

NCT Number	NCT05435014
Lead Sponsor	T-ACE Medical Co., Ltd
Conditions	Hepatocellular Carcinoma
Enrollment	2 participants
Start Date	2022-09-13
Primary Completion	2026-06-15 (estimated)
Study Completion	2026-06-15 (estimated)
Updated on ClinicalTrials.gov	2026-08-18